Atlas Trials

A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A Day

Clinical trial NCT04267380 · COMPLETED

Trial details

NCT number
NCT04267380
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Arthritis Rheumatoid
Start date
2018-09-30
Primary completion
2019-08-31
Enrollment
298

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.